OxyContin patent expiry poses tough choice for Ottawa

The federal health minister has two weeks to decide whether to allow drug companies to make a cheaper generic version of OxyContin, the much-prescribed painkiller that was pulled from the market after reports of abuse and rising addictions across Canada.

Read the whole article on CBC: Health

More from CBC: Health